GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.36
-0.09 (-6.21%)
At close: Aug 15, 2025, 3:59 PM
1.36
-0.37%
After-hours: Aug 15, 2025, 06:10 PM EDT
-6.21% (1D)
| Bid | 1.1 |
| Market Cap | 4.3M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.67M |
| EPS (ttm) | -5.63 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | -1.75 |
| Analyst | Buy |
| Ask | 1.46 |
| Volume | 262,464 |
| Avg. Volume (20D) | 97,148 |
| Open | 1.46 |
| Previous Close | 1.45 |
| Day's Range | 0.96 - 1.46 |
| 52-Week Range | 0.96 - 4.10 |
| Beta | 1.33 |
About GTBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GTBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GTBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
GT Biopharma shares are trading lower. The company...
Unlock content with
Pro Subscription
5 months ago
+21.18%
GT Biopharma shares are trading higher after the company announced a request for the withdrawal of form S-1 registration with the SEC.
